ATE312079T1 - Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion - Google Patents

Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion

Info

Publication number
ATE312079T1
ATE312079T1 AT99913888T AT99913888T ATE312079T1 AT E312079 T1 ATE312079 T1 AT E312079T1 AT 99913888 T AT99913888 T AT 99913888T AT 99913888 T AT99913888 T AT 99913888T AT E312079 T1 ATE312079 T1 AT E312079T1
Authority
AT
Austria
Prior art keywords
nonnucleosides
treatment
reverse transcriptase
hiv infection
transcriptase inhibitors
Prior art date
Application number
AT99913888T
Other languages
English (en)
Inventor
Rakesh Vig
Chen Mao
Fatih M Uckun
Original Assignee
Parker Hughes Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Inst filed Critical Parker Hughes Inst
Application granted granted Critical
Publication of ATE312079T1 publication Critical patent/ATE312079T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT99913888T 1998-03-17 1999-03-16 Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion ATE312079T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/040,538 US5998411A (en) 1998-03-17 1998-03-17 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
PCT/US1999/005602 WO1999047501A2 (en) 1998-03-17 1999-03-16 Nonnucleoside inhibitors of reverse transcriptase for the treatment of hiv-infection

Publications (1)

Publication Number Publication Date
ATE312079T1 true ATE312079T1 (de) 2005-12-15

Family

ID=21911533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913888T ATE312079T1 (de) 1998-03-17 1999-03-16 Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion

Country Status (11)

Country Link
US (8) US5998411A (de)
EP (2) EP1528057A1 (de)
JP (1) JP2002506854A (de)
CN (1) CN1301254A (de)
AP (1) AP2000001944A0 (de)
AT (1) ATE312079T1 (de)
AU (1) AU752010B2 (de)
CA (1) CA2323418A1 (de)
DE (1) DE69928779T2 (de)
EA (1) EA200000958A1 (de)
WO (1) WO1999047501A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998411A (en) 1998-03-17 1999-12-07 Hughes Institute Heterocyclic nonnucleoside inhibitors of reverse transcriptase
IT1305313B1 (it) * 1998-07-17 2001-05-04 Colla Paolo 3,4 - diidro- 6- benzil-4-oxopirimidine sostituite e relativo processodi produzione e impiego nella terapia delle infezioni da hiv-1.
US6136335A (en) * 1998-12-31 2000-10-24 Hughes Institute Phenethyl-5-bromopyridylthiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DABO) derivatives exhibiting spermicidal activity
US7186736B1 (en) * 1999-03-20 2007-03-06 Parker Hughes Institute NNI for treatment of multi-drug resistant HIV
US6207688B1 (en) 1999-06-23 2001-03-27 Parker Hughes Institute Phenethyl-thiourea compounds and use
US6545152B1 (en) * 2000-07-18 2003-04-08 Parker Hughes Institute R-isomers of nonnucleoside inhibitors
US6960606B2 (en) * 2000-10-19 2005-11-01 Parker Hughes Institute Adamantyl Thiazole Thioureas
US6689793B2 (en) * 2000-12-06 2004-02-10 Parker Hughes Institute Piperidinylethyl-, phenoxyethyl-, and β-fluorophenethyl-substituted thiourea compounds with potent anti-HIV activity
SE0100733D0 (sv) 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
TW200600492A (en) 2004-05-18 2006-01-01 Achillion Pharmaceuticals Inc Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
US7892618B2 (en) 2005-03-21 2011-02-22 Sony Corporation Deterring theft of optical media
US7702625B2 (en) * 2006-03-03 2010-04-20 International Business Machines Corporation Building a unified query that spans heterogeneous environments
SG174016A1 (en) * 2006-07-24 2011-09-29 Korea Res Inst Chem Tech Hiv reverse transcriptase inhibitors
KR20100041798A (ko) * 2007-06-29 2010-04-22 한국화학연구원 신규 ｈｉｖ 역전사효소 억제제
CN101784532B (zh) * 2007-06-29 2014-10-22 韩国化学研究院 Hiv逆转录酶抑制剂
KR20100092960A (ko) * 2007-12-21 2010-08-23 한국화학연구원 Ｈｉｖ 역전사 효소 억제제의 제조 방법
CN103288719A (zh) * 2012-03-05 2013-09-11 苏州欧凯医药技术有限公司 非核甘艾滋病毒抑制物-吡啶酮类先导体的合成
US9471130B2 (en) * 2013-10-25 2016-10-18 Advanced Micro Devices, Inc. Configuring idle states for entities in a computing device based on predictions of durations of idle periods
CN107301327A (zh) * 2017-05-17 2017-10-27 华南理工大学 一种使用计算机模拟金属配合物与dna相互作用的方法
CN108010101A (zh) * 2017-12-18 2018-05-08 重庆大学 一种绘制分子片段2d投影图的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950006713B1 (ko) * 1988-03-31 1995-06-21 미쓰비시 가세이 가부시끼가이샤 6-치환 비환식 피리미딘뉴클레오시드 유도체 및 그 유도체를 유효성분으로 하는 항 비루스제
US5686428A (en) * 1989-04-07 1997-11-11 Aktiebolaget Astra Pharmaceutical composition
HU205917B (en) 1989-09-29 1992-07-28 Mitsubishi Chem Ind Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components
CA2039039C (en) * 1990-03-29 2001-05-15 Tadashi Miyasaka Pyrimidine nucleoside derivative and antiviral agent containing the derivative as active ingredient
US5503978A (en) * 1990-06-11 1996-04-02 University Research Corporation Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) 1991-08-02 1998-08-16 Medivir Ab Thiourea derivatives for use in the preparation of medicaments for the inhibition of hiv and the treatment of aids and some such novel compounds
JPH0725770A (ja) * 1993-07-09 1995-01-27 Mitsubishi Chem Corp 経皮吸収性抗ウイルス剤
DE69414708T2 (de) 1993-08-24 1999-04-15 Medivir Ab, Huddinge Verbindungen und methoden zur inhibition von hiv und verwandten viren
US5998411A (en) 1998-03-17 1999-12-07 Hughes Institute Heterocyclic nonnucleoside inhibitors of reverse transcriptase

Also Published As

Publication number Publication date
US6925388B1 (en) 2005-08-02
US6180654B1 (en) 2001-01-30
EP1528057A1 (de) 2005-05-04
US6156759A (en) 2000-12-05
AU752010B2 (en) 2002-09-05
JP2002506854A (ja) 2002-03-05
US6380190B1 (en) 2002-04-30
AU3186499A (en) 1999-10-11
EP1064263B1 (de) 2005-12-07
AP2000001944A0 (en) 2000-12-31
US5998411A (en) 1999-12-07
CA2323418A1 (en) 1999-09-23
US20050153995A1 (en) 2005-07-14
US6124307A (en) 2000-09-26
DE69928779T2 (de) 2006-11-02
DE69928779D1 (de) 2006-01-12
US6300351B1 (en) 2001-10-09
WO1999047501A2 (en) 1999-09-23
EA200000958A1 (ru) 2001-06-25
EP1064263A2 (de) 2001-01-03
CN1301254A (zh) 2001-06-27
WO1999047501A3 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
DE69928779D1 (de) Nichtnukleoside reverse transkriptase-hemmer zur behandlung von hiv-infektion
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60219292D1 (de) Pyrazolderivate zur behandlung von hiv
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE451921T1 (de) Phenylindole zur behandlung von hiv
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
ATE253914T1 (de) Farnesyl protein transferase inhibitoren zur behandlung von arthropathien
DE60114580D1 (de) Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60045386D1 (de) Gerät zur thermischen behandlung von bandscheiben
DE69926385D1 (de) Behandlung von geweben
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60019195D1 (de) Behandlung durch Ablation von Knochenmetastasen
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
ATE279386T1 (de) Retinoide zur behandlung von emphysem
DE60035326D1 (de) Verfahren zur Behandlung von Abwasser
EP1117431A4 (de) Behandlung von acidose
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties